These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

176 related articles for article (PubMed ID: 20573093)

  • 1. Acute liver damage due to Serenoa repens: a case report.
    Lapi F; Gallo E; Giocaliere E; Vietri M; Baronti R; Pieraccini G; Tafi A; Menniti-Ippolito F; Mugelli A; Firenzuoli F; Vannacci A
    Br J Clin Pharmacol; 2010 May; 69(5):558-60. PubMed ID: 20573093
    [No Abstract]   [Full Text] [Related]  

  • 2. Serenoa repens and benign prostatic hyperplasia: no more effective than placebo.
    Prescrire Int; 2010 Aug; 19(108):181-2. PubMed ID: 20941857
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Serenoa repens in benign prostatic hypertrophy: analysis of 2 Italian studies.
    Mantovani F
    Minerva Urol Nefrol; 2010 Dec; 62(4):335-40. PubMed ID: 20944533
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Serenoa repens in benign prostatic hyperplasia].
    Log T
    Tidsskr Nor Laegeforen; 2008 May; 128(11):1293-4. PubMed ID: 18511974
    [TBL] [Abstract][Full Text] [Related]  

  • 5. 15 years' survey of safety and efficacy of Serenoa repens extract in benign prostatic hyperplasia patients with risk of progression.
    Vinarov AZ; Spivak LG; Platonova DV; Rapoport LM; Korolev DO
    Urologia; 2019 Feb; 86(1):17-22. PubMed ID: 29741118
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Serenoa repens (Saw Palmetto).
    Donato A
    J Soc Integr Oncol; 2008; 6(1):41-2. PubMed ID: 18302910
    [No Abstract]   [Full Text] [Related]  

  • 7. [Symptomatic treatment of benign hypertrophy of the prostate. Comparative study of prazosin and serenoa repens].
    Adriazola Semino M; Lozano Ortega JL; García Cobo E; Tejeda Báñez E; Romero Rodríguez F
    Arch Esp Urol; 1992 Apr; 45(3):211-3. PubMed ID: 1384438
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Phytotherapy for benign prostatic hyperplasia.
    Wilt TJ; Ishani A; Rutks I; MacDonald R
    Public Health Nutr; 2000 Dec; 3(4A):459-72. PubMed ID: 11276294
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Extract of Serenoa repens in the treatment of benign prostatic hyperplasia and lower urinary tract symptoms].
    Amdii RE; Al' Shukri AS
    Urologiia; 2018 May; (2):114-120. PubMed ID: 29901305
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [The results of the 10-year study of efficacy and safety of Serenoa repens extract in patients at risk of progression of benign prostatic hyperplasia].
    Aliaev IuG; Vinarov AZ; Demidko IuL; Spivak LG
    Urologiia; 2013; (4):32-6. PubMed ID: 24159762
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [A comparative analysis of the effectiveness of serenoa repens and serenoa repens in combination with urtica dioiccus for lower urinary symptoms suggestive of benign prostatic hyperplasia associated with chronic inflammation in prostate tissue].
    Ibishev KS; Krainy PA; Mitusov VV; Sizyakin DV; Magomedov GA
    Urologiia; 2019 Apr; (1):40-46. PubMed ID: 31184016
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Serenoa repens induced erectile dysfunction: Underdiagnosis and phytovigilance.
    Gallo E; Maggini V; Lombardi N; Crescioli G; Sivelli F; Vannacci A; Firenzuoli F
    Br J Clin Pharmacol; 2022 May; 88(5):2441-2443. PubMed ID: 34747053
    [No Abstract]   [Full Text] [Related]  

  • 13. Phytotherapy in the treatment of benign prostatic hyperplasia.
    Lowe FC; Fagelman E
    Curr Opin Urol; 2002 Jan; 12(1):15-8. PubMed ID: 11753128
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Efficacy and Safety of Serenoa repens Extract Among Patients with Benign Prostatic Hyperplasia in China: A Multicenter, Randomized, Double-blind, Placebo-controlled Trial.
    Ye Z; Huang J; Zhou L; Chen S; Wang Z; Ma L; Wang D; Wang G; Wang S; Liang C; Qiu S; Gu X; Liu J; Weng Z; Wu C; Wei Q; Xie L; Wu W; Cheng Y; Hu J; Wang Z; Zeng X
    Urology; 2019 Jul; 129():172-179. PubMed ID: 30880074
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Long-term efficacy of Serenoa repens treatment in patients with mild and moderate symptomatic benign prostatic hyperplasia.
    Sinescu I; Geavlete P; Multescu R; Gangu C; Miclea F; Coman I; Ioiart I; Ambert V; Constantin T; Petrut B; Feciche B
    Urol Int; 2011; 86(3):284-9. PubMed ID: 21304222
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Observational database serenoa repens (DOSSER): overview, analysis and results. A multicentric SIUrO (Italian Society of Oncological Urology) project.
    Bertaccini A; Giampaoli M; Cividini R; Gattoni GL; Sanseverino R; Realfonso T; Napodano G; Fandella A; Guidoni E; Prezioso D; Galasso R; Cicalese C; Scattoni V; Armenio A; Conti G; Corinti M; Spasciani R; Liguori G; Lampropoulou N; Martorana G
    Arch Ital Urol Androl; 2012 Sep; 84(3):117-22. PubMed ID: 23210402
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Serenoa repens extract for benign prostate hyperplasia: a randomized controlled trial.
    Willetts KE; Clements MS; Champion S; Ehsman S; Eden JA
    BJU Int; 2003 Aug; 92(3):267-70. PubMed ID: 12887481
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Serenoa repens for benign prostatic hyperplasia.
    Wilt T; Ishani A; Mac Donald R
    Cochrane Database Syst Rev; 2002; (3):CD001423. PubMed ID: 12137626
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Hepatotoxicity potential of saw palmetto (Serenoa repens) in rats.
    Singh YN; Devkota AK; Sneeden DC; Singh KK; Halaweish F
    Phytomedicine; 2007 Feb; 14(2-3):204-8. PubMed ID: 16854576
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Prediction of the effectiveness of the therapy of LUTS/BPH by Serenoa repens extracts].
    Sivkov AV; Golovanov SA; Zhukova LV
    Urologiia; 2019 Jul; (3):14-22. PubMed ID: 31356008
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.